Related Experiment Videos
[Laser trabeculopuncture. III Experiments with rhesus monkeys]
Abstract:
Argon-laser trabeculopuncture was carried out on 7 rhesus monkeys. Perforation of the trabecular meshwork was possible with laser impacts of 100 msec, 4,200 mW and a beam diameter of 50 mum. Clinical and histological observations covered an interval of up to 15 weeks after coagulation. They revealed an obliteration of both the trabecular holes and the canal of Schlemm after a few days. Shorter pulse durations and higher energies might be helpful to improve the effectiveness, possibly assisted by a therapy with anti-inflammatory agents.
Insights
Argon-laser trabeculopuncture in rhesus monkeys showed that laser impacts caused obliteration of the trabecular meshwork and Schlemm’s canal within days. Further research may improve effectiveness with shorter pulses, higher energies, and anti-inflammatory agents.
Area of Science:
- Ophthalmology
- Laser Surgery
- Ocular Anatomy
Context:
- Investigating the efficacy of argon-laser trabeculopuncture for glaucoma treatment.
- Utilizing rhesus monkeys as a preclinical model for ocular procedures.
Purpose:
- To evaluate the immediate and short-term effects of argon-laser trabeculopuncture on the trabecular meshwork and Schlemm's canal.
- To determine optimal laser parameters for successful trabecular meshwork perforation.
Summary:
- Argon-laser trabeculopuncture was performed on seven rhesus monkeys using specific laser parameters (100 msec, 4,200 mW, 50 µm beam diameter).
- Clinical and histological examinations up to 15 weeks post-procedure revealed rapid obliteration of laser-created trabecular holes and Schlemm's canal.
- The study suggests that shorter pulse durations and higher laser energies, potentially combined with anti-inflammatory agents, could enhance the procedure's effectiveness.
Impact:
- Provides insights into the immediate tissue response following laser trabeculopuncture.
- Highlights potential limitations of current argon-laser parameters in maintaining trabecular patency.
- Suggests avenues for optimizing laser parameters and adjunctive therapies for glaucoma treatment.